Clinical trial
Dendritic Cell Vaccine for Head and Neck Cancer
NCT00492947 · University of Maryland, Baltimore, Other · Withdrawn
Key facts
| NCT number | NCT00492947 |
|---|---|
| Title | Dendritic Cell Vaccine for Head and Neck Cancer |
| Official title | 0608 GCC:Phase I Study of Intra-tumoral Injection of Dendritic Cells for the Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
| Acronym | Dendritic |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Squamous Cell Carcinoma of Head and Neck |
| Intervention type | Biological |
| Interventions | dendritic cell vaccine |
| Enrollment | 0 |
| Start date | Jun 1, 2007 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2012 |
| First posted | Jun 27, 2007 |
| Last update posted | Apr 30, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: